Titan Pharmaceuticals Inc. (TTNP)
$4.61
$0.00 (0.00%)As on 02-Oct-2025 09:30EDT
Market cap
$6 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
29.94
-
EV/EBITDA
-0.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-3
-
Face value
--
-
Shares outstanding
1,330,234
10 Years Aggregate
CFO
$-84.33 Mln
EBITDA
$-75.11 Mln
Net Profit
$-92.55 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Titan Pharmaceuticals (TTNP)
| 41.4 | 16.4 | 8.2 | -11.4 | -40.2 | -45.8 | -55.0 |
|
BSE Sensex*
| -11.7 | -2.7 | -8.0 | -8.0 | 6.2 | 7.8 | 10.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Titan Pharmaceuticals (TTNP)
| -59.9 | -47.6 | -23.5 | -69.0 | -43.5 | -85.5 | -83.0 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Titan Pharmaceuticals (TTNP)
As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the... treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York. Read more
-
CEO & Principal Financial Officer
Mr. David Elliot Lazar
-
CEO & Principal Financial Officer
Mr. David Elliot Lazar
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Titan Pharmaceuticals (TTNP)
What is the current share price of Titan Pharmaceuticals Inc (TTNP) Today?
The share price of Titan Pharmaceuticals Inc (TTNP) is $4.61 (NASDAQ) as of 02-Oct-2025 09:30 EDT. Titan Pharmaceuticals Inc (TTNP) has given a return of -40.24% in the last 3 years.
What is the current PB & PE ratio of Titan Pharmaceuticals Inc (TTNP)?
Since, TTM earnings of Titan Pharmaceuticals Inc (TTNP) is negative, P/E ratio is not available.
The P/B ratio of Titan Pharmaceuticals Inc (TTNP) is 2.20 times as on 02-Oct-2025, a 64 discount to its peers’ median range of 6.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-0.62
|
1.20
|
|
2023
|
-0.55
|
0.47
|
|
2022
|
-0.57
|
4.25
|
|
2021
|
-0.25
|
0.40
|
|
2020
|
-0.32
|
1.86
|
What is the 52 Week High and Low of Titan Pharmaceuticals Inc (TTNP)?
The 52-week high and low of Titan Pharmaceuticals Inc (TTNP) are Rs 5.76 and Rs 3.03 as of 29-May-2026.
What is the market cap of Titan Pharmaceuticals Inc (TTNP)?
Titan Pharmaceuticals Inc (TTNP) has a market capitalisation of $ 6 Mln as on 02-Oct-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Titan Pharmaceuticals Inc (TTNP)?
Before investing in Titan Pharmaceuticals Inc (TTNP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.